Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study.
Cancer Med
; 12(2): 1869-1877, 2023 01.
Article
en En
| MEDLINE
| ID: mdl-35796421
ABSTRACT
Participation in cancer research trials by minority populations is imperative in reducing disparities in clinical outcomes. Even with increased awareness of the importance of minority patient inclusion in clinical research to improve cancer care and survival, significant barriers persist in accruing and retaining minority patients into clinical trials. This study sought to identify and address barriers to minority accrual to a minimal risk clinical research study in real-time.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
Problema de salud:
1_desigualdade_iniquidade
Asunto principal:
Ensayos Clínicos como Asunto
/
Grupos Minoritarios
Límite:
Humans
Idioma:
En
Revista:
Cancer Med
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos